We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+8.7%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$117B
AUM Growth
+$10.7B
(+10%)
Cap. Flow
+$2.51B
Cap. Flow
% of AUM
2.14%
Top 10 Holdings %
Top 10 Hldgs %
45.31%
Holding
3,828
New
377
Increased
1,948
Reduced
1,225
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$499M |
| 2 |
Vanguard Total Bond Market
BND
|
+$461M |
| 3 |
Avantis International Small Cap Value ETF
AVDV
|
+$292M |
| 4 |
Avantis US Small Cap Value ETF
AVUV
|
+$289M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$336M |
| 2 |
Fidelity Total Bond ETF
FBND
|
+$135M |
| 3 |
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
|
+$82.5M |
| 4 |
iShares National Muni Bond ETF
MUB
|
+$81.2M |
| 5 |
JPMorgan BetaBuilders US Equity ETF
BBUS
|
+$70.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.01% |
| 2 | Financials | 3.7% |
| 3 | Consumer Discretionary | 1.92% |
| 4 | Communication Services | 1.73% |
| 5 | Healthcare | 1.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
MIRA Pharmaceuticals
MIRA
$37.1M
| $27.3K | ﹤0.01% |
+22,599
| New | +$26.1K |
|
3577
Marker Therapeutics
MRKR
$20.3M
| $26.5K | ﹤0.01% |
17,312
| – | – |
|
3578
Solid Power
SLDP
$468M
| $26.1K | ﹤0.01% |
+11,913
| New | +$16.7K |
|
3579
Advantage Solutions
ADV
$484M
| $25.7K | ﹤0.01% |
+778
| New | +$25.6K |
|
3580
Caribou Biosciences
CRBU
$156M
| $25.4K | ﹤0.01% |
+20,171
| New | +$19.8K |
|
3581
Wheels Up
UP
$220M
| $25.1K | ﹤0.01% |
+1,174
| New | +$28.9K |
|
3582
Prime Medicine
PRME
$533M
| $25.1K | ﹤0.01% |
+10,145
| New | +$15.6K |
|
3583
Immunic
IMUX
$182M
| $24.4K | ﹤0.01% |
3,500
| – | – |
|
|
ONL
3584
Orion Office REIT
ONL
$148M
| $24.4K | ﹤0.01% |
+11,454
| New | +$21.8K |
|
3585
Microvision
MVIS
$88.2M
| $23.7K | ﹤0.01% |
20,750
-1,246
| -6% | -$1.44K |
|
3586
Biomea Fusion
BMEA
$90.4M
| $23.6K | ﹤0.01% |
13,128
+684
| +5% | +$1.32K |
|
3587
Douglas Elliman
DOUG
$155M
| $23.4K | ﹤0.01% |
10,078
-1
| -0% | -$2 |
|
3588
Fortress Biotech
FBIO
$111M
| $23.2K | ﹤0.01% |
+12,452
| New | +$21.6K |
|
|
SSKN
3589
DELISTED
Strata Skin Sciences
SSKN
| $22.9K | ﹤0.01% |
10,016
| – | – |
|
3590
PUT
Deere & Co
DE
$170B
| $22.7K | ﹤0.01% |
+2,900
| New | +$1.42M |
|
|
BNKK
3591
Bonk Inc
BNKK
$8.96M
| $22.4K | ﹤0.01% |
1,944
+87
| +5% | +$1.17K |
|
3592
SAB Biotherapeutics
SABS
$268M
| $20.8K | ﹤0.01% |
+11,852
| New | +$19.6K |
|
3593
Polestar Automotive Holding UK
PSNY
$1.98B
| $20.5K | ﹤0.01% |
640
-8
| -1% | -$254 |
|
3594
PUT
Netflix
NFLX
$292B
| $19.6K | ﹤0.01% |
+4,000
| New | +$452K |
|
3595
PUT
Alphabet (Google) Class A
GOOGL
$3.91T
| $18.9K | ﹤0.01% |
+8,000
| New | +$1.31M |
|
3596
Gevo
GEVO
$397M
| $18.7K | ﹤0.01% |
14,153
-11,829
| -46% | -$13.9K |
|
3597
PUT
Palantir
PLTR
$295B
| $16.9K | ﹤0.01% |
+2,000
| New | +$235K |
|
|
MKZR
3598
MacKenzie Realty Capital
MKZR
$3.52M
| $16.3K | ﹤0.01% |
2,436
+425
| +21% | +$4.37K |
|
3599
Solitario Resources
XPL
$68.1M
| $16.3K | ﹤0.01% |
25,000
| – | – |
|
3600
Kopin
KOPN
$663M
| $16.2K | ﹤0.01% |
10,587
-4,351
| -29% | -$5.67K |
|
Similar funds
Creative Planning's Q2 2025 Portfolio in Review
As of Q2 2025, Creative Planning held 3,828 positions worth $117B, up 10% from $106B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Creative Planning's Q2 2025 filing shows 377 new, 1,948 increased, 1,225 reduced and 150 closed positions. Its largest new stake was CoreWeave: 140,135 shares worth $22.9M. The largest sale was Vanguard FTSE Developed Markets ETF, an estimated $336M.
By sector, the portfolio is most concentrated in Technology at 7% of assets, up from 6.3% a quarter earlier, followed by Financials and Consumer Discretionary.
- Creative Planning's largest Q2 2025 buy was CoreWeave: 140,135 shares worth $22.9M.
- Creative Planning added most to State Street SPDR Portfolio Developed World ex-US ETF in Q2 2025, an estimated $499M increase.
- Creative Planning's biggest Q2 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $336M.
- Creative Planning fully exited Discover Financial Services in Q2 2025, selling an estimated $12.3M.
- Creative Planning's ten largest holdings make up 45% of its $117B portfolio in Q2 2025.
- Creative Planning opened 377 new positions and closed 150 in Q2 2025.
- Creative Planning's portfolio value rose 10% quarter-over-quarter to $117B.
Based on Creative Planning's 13F filing for Q2 2025, filed 8 Aug 2025.